Literature DB >> 27107584

Identification of patients with atrial fibrillation in UK community pharmacy: an evaluation of a new service.

M J Twigg1, T Thornley2, N Scobie3.   

Abstract

Background Many patients with atrial fibrillation (AF) are asymptomatic and diagnosed via opportunistic screening. Community pharmacy has been advocated as a potential resource for opportunistic screening and lifestyle interventions. Objective The objective of this evaluation is to describe the outcomes from an AF service, in terms of referrals and interventions provided to patients identified as not at risk. Methods Eligibility was assessed from pharmacy records and the completion of a short questionnaire. Once consented, patients were screened for AF and their blood pressure was measured. Results Of 594 patients screened, nine were identified as at risk of having AF and were referred to their GP. The service also identified 109 patients with undiagnosed hypertension, 176 patients with a Body Mass Index >30, 131 with an Audit-C score >5 and 59 smokers. Pharmacists provided 413 interventions in 326 patients aimed at weight reduction (239), alcohol consumption (123) and smoking cessation (51). Conclusion This evaluation characterises the interventions provided to, not only those identified with the target condition-in this case AF-but also those without it. The true outcome of these additional interventions, along with appropriate follow-up, should be the focus of future studies.

Entities:  

Keywords:  Atrial fibrillation; Community pharmacy; Pharmacy services; Risk assessment; United Kingdom

Mesh:

Year:  2016        PMID: 27107584     DOI: 10.1007/s11096-016-0303-8

Source DB:  PubMed          Journal:  Int J Clin Pharm


  8 in total

Review 1.  Atrial fibrillation.

Authors:  Gregory Y H Lip; Hung Fat Tse; Deirdre A Lane
Journal:  Lancet       Date:  2011-12-11       Impact factor: 79.321

2.  Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.

Authors:  Nicole Lowres; Lis Neubeck; Glenn Salkeld; Ines Krass; Andrew J McLachlan; Julie Redfern; Alexandra A Bennett; Tom Briffa; Adrian Bauman; Carlos Martinez; Christopher Wallenhorst; Jerrett K Lau; David B Brieger; Raymond W Sy; S Ben Freedman
Journal:  Thromb Haemost       Date:  2014-04-01       Impact factor: 5.249

3.  A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.

Authors:  F D R Hobbs; D A Fitzmaurice; J Mant; E Murray; S Jowett; S Bryan; J Raftery; M Davies; G Lip
Journal:  Health Technol Assess       Date:  2005-10       Impact factor: 4.014

4.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

5.  The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study.

Authors:  Bernd Brüggenjürgen; Karin Rossnagel; Stephanie Roll; Fredrik L Andersson; Dagmar Selim; Jacqueline Müller-Nordhorn; Christian H Nolte; Gerhard J Jungehülsing; Arno Villringer; Stefan N Willich
Journal:  Value Health       Date:  2007 Mar-Apr       Impact factor: 5.725

Review 6.  Public health in community pharmacy: a systematic review of pharmacist and consumer views.

Authors:  Claire E Eades; Jill S Ferguson; Ronan E O'Carroll
Journal:  BMC Public Health       Date:  2011-07-21       Impact factor: 3.295

7.  Community pharmacy type 2 diabetes risk assessment: demographics and risk results.

Authors:  Michael J Twigg; David J Wright; Tracey Thornley; Lisa Haynes
Journal:  Int J Pharm Pract       Date:  2014-07-22

8.  The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting.

Authors:  Andrew Willis; Peter Rivers; Laura J Gray; Melanie Davies; Kamlesh Khunti
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  8 in total
  3 in total

1.  Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study.

Authors:  Filipa Alves da Costa; Katerina Mala-Ladova; Vivian Lee; Salvador Tous; John Papastergiou; Dale Griffiths; Marie-Camille Chaumais; Kurt E Hersberger; Reka Viola; Ema Paulino; Trudie Lobban; Lis Neubeck; Ben Freedman; Sotiris Antoniou
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

2.  Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol.

Authors:  Emma L Veale; Adrian J Stewart; Alistair Mathie; Satvinder K Lall; Melanie Rees-Roberts; Vilius Savickas; Sukvinder K Bhamra; Sarah A Corlett
Journal:  BMJ Open       Date:  2018-03-14       Impact factor: 2.692

3.  Pharmacy-Based Opportunistic Atrial Fibrillation Screening at a Community Level: A Real-Life Study.

Authors:  Stephane Olindo; Pauline Renou; François Martial; Nathalie Heyvang; Lea Milan; Sylvain Ledure; François Rouanet
Journal:  Healthcare (Basel)       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.